glp 1 compound tirzepatide Injectable | Compounded GLP-1/GIP Pricing is for a 28 Compounded Semaglutide vs. Compounded Tirzepatide:

Clinical trial data from the STEP program showed that semaglutide 2.4mg weekly produced average weight loss of 14.9% of body weight over 68 weeks, compared to tirzepatide at 15mg which achieved approximately 22.5% in the SURMOUNT trials

Liraglutide was therefore the first long-acting GLP-1 receptor agonist with continuous efficacy over a 24 h period

JAMA Netw Open 7, e2416578 (2024)

"There have been growing reports of [eye] adverse events with GLP-1 receptor agonists, but no clear consensus regarding their impact on age-related macular degeneration (AMD) progression," study author Dr

Cell Metabolism , 34 (9), 1234-1247